Clinical Trials Arena
60 Degrees pauses Phase IIB Covid-19 trial for tafenoquine
The company plans to refile the IND after assessing the feasibility of US FDA-suggested trial modifications.
Filings signal: ARCA’s Q2 2023 reports
Patents signal: Chinese Academy of Sciences tops assignees for Q2 2023
Jobs signal: RWJ remains lead for active job listings after 30 days
Pipeline Moves: Advancement prospects drop for Novartis oncology drug after trial termination
Tweets of the week: Metabolic disorders, most discussed therapy area
